Navitrux Injection, Powder, Lyophilized, For Solution
Product Images NDC 83831-153
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Navitrux (NDC 83831-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avyxa Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Navitrux (fosaprepitant) For Injection, 150 mg/vial (Carton Label)
Navitrux (fosaprepitant) For Injection, 150 mg/vial (Container Label)
Image (9cb1a2a0 B0ae 4825 A67a 31c42ef69edd 140 2)
Image (Ce45271c 40ab 4ce2 B399 198cfb1253a5 136 1)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.